Seong-Chul Kim
Direktor/Vorstandsmitglied bei KPS CORPORATION
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Seong-Chul Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KPS CORPORATION | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Seong-Chul Kim
Ehemalige bekannte Positionen von Seong-Chul Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
LSK Investment Co. Ltd.
 LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Vorstandsvorsitzender | 11.04.2016 | 31.12.2018 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Gründer | 01.01.2005 | - | |
| Präsident | 01.01.2005 | - | |
| HLB CO., LTD. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - |
Statistik
International
| Südkorea | 3 |
| Vereinigte Staaten | 2 |
| 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HLB CO., LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
LSK Investment Co. Ltd.
LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Finance |
| KPS Corp. (South Korea) |
- Börse
- Insiders
- Seong-Chul Kim
- Erfahrung